Page 10 - The Indian EYE 092421

NATION SEPTEMBER 17, 2021 | The Indian Eye 10

vaCCine issue

how Covishield sparked a

controversy over travel advisory

between india and uK

A study says that a combination of Covaxin and Covishield vaccines has elicited

better safety and immunogenicity results

Our Bureau

London/New Delhi

nited Kingdom govern-
ment on Wednesday in
Uits revised travel advi-
sory said that Covishield is qual-
ified as an approved vaccine.
Earlier, the UK government did
not accept people vaccinated
with Covishield and considered
them as unvaccinated. The need
for them to go through 10-day
quarantine was criticized in In-
dia. The new travel advisory by
the UK stated that the four list-
ed vaccines, such as AstraZen-
eca Covishield, AstraZeneca
Vaxzevria and Moderna Takeda,
qualify as approved vaccines.
But there is still confusion
over the United Kingdom’s A health worker inoculates a girl with the first dose of the Covishield vaccine in New Delhi (ANI)
vaccine recognition process for
Indian travellers. Even though not Covishield if the issue is not travelling to the UK. I am told India to the UK, be it tourists,
UK’s new travel rules state satisfactorily resolved. that certain assurances have business people or students.
that AstraZeneca Covishield is Foreign Secretary Harsh been given that this issue will be Over 62,500 student visas have
among vaccines that qualify as Vardhan Shringla told media resolved,” he added. been issued in the year ending
approved, India is not yet on the persons on Tuesday that Exter- Amid concerns in India June 2021, which is an increase
list of 17 countries mentioned. nal Affairs Minister S Jaishan- about UK’s new travel rules, of almost 30 per cent as com-
The ‘changes to international kar had raised the issue strongly British High Commissioner to pared to the previous year,”
travel rules’ state that formu- with the UK. India Alex Ellis on Wednes- Ellis said in a statement. “We
lations of the four listed vac- “Have raised the discrim- day said that Covishield is not have been having detailed tech-
cines, such as AstraZeneca Co- inatory nature of UK vaccine a problem and detailed tech- nical discussions regarding cer-
vishield, AstraZeneca Vaxzevria recognition for AstraZeneca nical discussions are being tification, with the builders of
and Moderna Takeda, qualify as but not Covishield. Discussions held regarding certification of the CoWIN app and the NHS
approved vaccines. on, but if they do not satisfy us, COVID-19 vaccine with the app, about both apps. They’re
Earlier, India had said on we would be well within our builders of CoWIN app and happening at a rapid pace, to
Tuesday that it will be within its rights to take reciprocal action,” NHS app. ensure that both countries mu-
rights to take reciprocal mea- Shringla had said. “We’re clear Covishield is tually recognize the vaccine cer-
sures against UK’s “discrimi- “Non-recognition of Cov- not a problem. The UK is open tificates issued by each other,”
natory” move to recognize As- ishield is a discriminating poli- to travel and we’re already see- he added.
traZeneca Covid-19 vaccine but cy and impacts Indian citizens ing a lot of people going from Continued on next page... >>

www.TheIndianEYE .com